The influence of developmental age on the early transcriptomic response of children with septic shock

Molecular Medicine

Volumn 17, Issue 11, 2011, Pages 1146-1156

  Wynn, James L ^a   Cvijanovich, Natalie Z ^b   Allen, Geoffrey L ^c   Thomas, Neal J ^d   Freishtat, Robert J ^e   Anas, Nick ^f   Meyer, Keith ^g   Checchia, Paul A ^h   Lin, Richard ⁱ   Shanley, Thomas P ^j   Bigham, Michael T ^k   Banschbach, Sharon ^l   Beckman, Eileen ^l   Wong, Hector R ^l  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d PENN STATE CHILDREN S HOSPITAL   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^g MIAMI CHILDREN'S HOSPITAL   (United States)

^h ST LOUIS CHILDREN S HOSPITAL   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j UNIVERSITY OF MICHIGAN   (United States)

^k AKRON CHILDREN'S HOSPITAL   (United States)

^l UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ADAPTIVE IMMUNITY; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; IMMUNE RESPONSE; INFANT; INNATE IMMUNITY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPTIC SHOCK; TRANSCRIPTOMICS;

AGING; ANTIGEN PRESENTATION; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; INTERLEUKIN-10; LEUKOCYTES; MALE; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 82855164062     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.201     Document Type: Article

References (36)

1. Watson RS, Carcillo JA. (2005) Scope and epidemiology of pediatric sepsis. Pediatr. Crit. Care Med. 6:S3-5.
2. Mathews TJ, MacDorman MF. (2008) Infant mortality statistics from the 2005 period linked birth/infant death data set. Natl. Vital Stat. Rep. 57:1-32.
3. Lawn JE, Cousens S, Zupan J. (2005) 4 million neonatal deaths: when? where? why? Lancet 365:891-900.
4. Checchia PA, et al. (2008) Myocardial transcriptional profiles in a murine model of sepsis: evidence for the importance of age. Pediatr Crit. Care Med. 9:530-5.
5. Wynn J, Cornell TT, Wong HR, Shanley TP, Wheeler DS. (2010) The host response to sepsis and developmental impact. Pediatrics. 125:1031-41.
6. Cvijanovich N, et al. (2008) Validating the genomic signature of pediatric septic shock. Physiol. Genomics. 34:127-34.
7. Ramilo O, et al. (2007) Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood. 109:2066-77.
8. Wong HR, et al. (2009) Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit. Care Med. 37:1558-66.
9. Wong HR, et al. (2009) Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med. 7:34.
10. Wong HR, et al. (2007) Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol. Genomics 30:146-55.
11. Goldstein B, Giroir B, Randolph A. (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr. Crit. Care Med. 6:2-8.
12. Shanley TP, et al. (2007) Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol. Med. 13:495-508.
13. Irizarry RA, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 4:249-64.
14. Calvano SE, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature. 437:1032-7.
15. Eichler GS, Huang S, Ingber DE. (2003) Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics. 19:2321-2.
16. Guo Y, Eichler GS, Feng Y, Ingber DE, Huang S. (2006) Towards a holistic, yet gene-centered analysis of gene expression profiles: a case study of human lung cancers. J. Biomed. Biotechnol. 2006:69141.
17. Wong HR, et al. (2010) Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit. Care Med. 38:1955-61.
18. Wynn JL, Wong HR. (2010) Pathophysiology and treatment of septic shock in neonates. Clin. Perinatol. 37:439-79.
19. Belderbos ME, et al. (2009) Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin. Immunol. 133:228-37.
20. Kollmann TR, et al. (2009) Neonatal innate TLRmediated responses are distinct from those of adults. J. Immunol. 183:7150-60.
21. Levy O. (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7:379-90.
22. Strunk T, Currie A, Richmond P, Simmer K, Burgner D. (2011) Innate immunity in human newborn infants: prematurity means more than immaturity. J. Matern. Fetal. Neonatal. Med. 24:25-31.
23. Wynn JL, Levy O. (2010) Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin. Perinatol. 37:307-37.
24. Bouchon A, Facchetti F, Weigand MA, Colonna M. (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 410:1103-7.
25. Wynn JL, et al. (2007) Increased mortality and alteredaltered immunity in neonatal sepsis produced by generalized peritonitis. Shock. 28:675-83.
26. Adkins B, Leclerc C, Marshall-Clarke S. (2004) Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553-64.
27. Wynn JL, et al. (2008) Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood. 112:1750-8.
28. Hotchkiss RS, et al. (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1:496-501.
29. Hotchkiss RS, Coopersmith CM, Karl IE. (2005) Prevention of lymphocyte apoptosis: a potential treatment of sepsis? Clin. Infect. Dis. 41 Suppl 7:S465-9.
30. Kalman L, et al. (2004) Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet. Med. 6:16-26.
31. Wynn JL, Neu J, Moldawer LL, Levy O. (2009) Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J. Perinatol. 29:79-88.
32. Wynn JL, Seed PC, Cotten CM. (2010) Does IVIg administration yield improved immune function in very premature neonates? J. Perinatol. 30:635-42.
33. Ito S, et al. (2005) CpG oligodeoxynucleotides enhance neonatal resistance to Listeria infection. J. Immunol. 174:777-82.
34. Pedras-Vasconcelos JA, et al. (2006) CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus. J. Immunol. 176:4940-9.
35. Sun L, Gorospe JR, Hoffman EP, Rao AK. (2007) Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/ RUNX1 mutation: insights from platelet expression profiling. J. Thromb. Haemost. 5:146-54.
36. Wong HR, Freishtat RJ, Monaco M, Odoms K, Shanley TP. (2010) Leukocyte subset-derived genomewide expression profiles in pediatric septic shock. Pediatr. Crit. Care Med. 11:349-55.